Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hyphens Pharma International Ltd. ( (SG:1J5) ) has issued an announcement.
Hyphens Pharma International Ltd. held its Annual General Meeting on April 28, 2025, where the company’s Chairman, Mr. Lim See Wah, presented the business and financial performance of the Group. The meeting emphasized transparency and shareholder rights, with all resolutions being voted on by poll, in accordance with the Listing Manual Section B: Rules of Catalist.
The most recent analyst rating on (SG:1J5) stock is a Buy with a S$0.40 price target. To see the full list of analyst forecasts on Hyphens Pharma International Ltd. stock, see the SG:1J5 Stock Forecast page.
More about Hyphens Pharma International Ltd.
Hyphens Pharma International Ltd. is a company incorporated in Singapore, operating in the pharmaceutical industry. It focuses on the development and distribution of health products and pharmaceuticals.
Average Trading Volume: 70,206
Technical Sentiment Signal: Buy
Current Market Cap: S$91.21M
Find detailed analytics on 1J5 stock on TipRanks’ Stock Analysis page.